Showing results (371-380 of 6,546) with videos related to
Sort By:
Pageof 655
Frontiers in Endocrinology|March 6, 2023
Molecular signatures distinguish senescent cells from inflammatory cells in aged mouse callus stromal cellsJiatong Liu, Xi Lin, Andrew McDavid, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 6, 2003
Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorptionLianping Xing, Louise Carlson, Beryl Story, et al.Investigative Ophthalmology & Visual Science|June 12, 2010
Optical coherence tomography may be used to predict visual acuity in patients with macular edemaLucia Pelosini, Christopher C Hull, James F Boyce, et al.Endocrinology|September 1, 1989
Effects of interleukin-1 on bone turnover in normal miceB F Boyce, T B Aufdemorte, I R Garrett, et al.Journal of Nephrology|August 17, 2001
The impact of bleeding times on major complication rates after percutaneous real-time ultrasound-guided renal biopsiesK P Stiles, C Hill, C J LeBrun, et al.Kidney International. Supplement|May 20, 2003
Regulation of bone remodeling and emerging breakthrough drugs for osteoporosis and osteolytic bone metastasesBrendan F Boyce, Lianping Xing, William Shakespeare, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 19, 2004
RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritisPing Li, Edward M Schwarz, Regis J O'Keefe, et al.Plos One|August 20, 2015
TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 ExpressionZhijun Zhao, Xiaodong Hou, Xiaoxiang Yin, et al.Cancer Immunology, Immunotherapy : CII|August 6, 2024
Chimeric antigen receptor dendritic cells targeted delivery of a single tumoricidal factor for cancer immunotherapyRong Duan, Philip Milton, Chutamath Sittplangkoon, et al.Annals of the Rheumatic Diseases|December 1, 1991
Clinical experience with pamidronate in the treatment of Paget's disease of boneS J Gallacher, B F Boyce, U Patel, et al.Pageof 655